Reactions of Anticancer Analogs with Proteins and DNA
2018
- 10Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage10
- Abstract Views10
Artifact Description
Several platinum (II) compounds are known to demonstrate anticancer activity. In particular, platinum compounds of a “triamine” structure are known to contribute significantly to cell toxicity. Here, we have investigated platinum triamine complex that mimics the size and shape of other potential anticancer drugs. We observed the reactions between our platinum compound and small-molecule models of proteins and DNA. Our platinum compound was reacted with an amino acid (N-acetyl-L-methionine) and a nucleotide (guanosine monophosphate) with the expectation that either the methionine or the guanine would react. However, under some conditions, both the methionine and the guanine were shown to react with the platinum compound. The unique behavior of our compound is one that may be exploited in the design of future platinum-based drugs. An insight into the conditions that cause such unusual behavior could potentially be used to improve the efficacy of anticancer drugs used in chemotherapeutics.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know